216 related articles for article (PubMed ID: 32225066)
1. The Expression of Selected Factors Related to T Lymphocyte Activity in Canine Mammary Tumors.
Bujak JK; Szopa IM; Pingwara R; Kruczyk O; Krzemińska N; Mucha J; Majchrzak-Kuligowska K
Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32225066
[TBL] [Abstract][Full Text] [Related]
2. Increased levels of interleukins 8 and 10 as findings of canine inflammatory mammary cancer.
de Andrés PJ; Illera JC; Cáceres S; Díez L; Pérez-Alenza MD; Peña L
Vet Immunol Immunopathol; 2013 Apr; 152(3-4):245-51. PubMed ID: 23351639
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-8 expression associated with canine mammary tumors.
Zuccari DA; Castro R; Gelaleti GB; Mancini UM
Genet Mol Res; 2011; 10(3):1522-32. PubMed ID: 21863548
[TBL] [Abstract][Full Text] [Related]
4. The metastatic cascade is reflected in the transcriptome of metastatic canine mammary carcinomas.
Klopfleisch R; Lenze D; Hummel M; Gruber AD
Vet J; 2011 Nov; 190(2):236-243. PubMed ID: 21112801
[TBL] [Abstract][Full Text] [Related]
5. Expression of HER-2 and nuclear localization of HER-3 protein in canine mammary tumors: histopathological and immunohistochemical study.
Kim JH; Im KS; Kim NH; Yhee JY; Nho WG; Sur JH
Vet J; 2011 Sep; 189(3):318-22. PubMed ID: 20947393
[TBL] [Abstract][Full Text] [Related]
6. Chemokine gene expression influences metastasis and survival time of female dogs with mammary carcinoma.
Ariyarathna H; Thomson N; Aberdein D; Munday JS
Vet Immunol Immunopathol; 2020 Sep; 227():110075. PubMed ID: 32590239
[TBL] [Abstract][Full Text] [Related]
7. Lymphocyte infiltration, expression of interleukin (IL) -1, IL-6 and expression of mutated breast cancer susceptibility gene-1 correlate with malignancy of canine mammary tumours.
Kim JH; Yu CH; Yhee JY; Im KS; Sur JH
J Comp Pathol; 2010; 142(2-3):177-86. PubMed ID: 19959182
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-8 as a prognostic serum marker in canine mammary gland neoplasias.
Gelaleti GB; Jardim BV; Leonel C; Moschetta MG; Zuccari DA
Vet Immunol Immunopathol; 2012 Apr; 146(2):106-12. PubMed ID: 22405680
[TBL] [Abstract][Full Text] [Related]
9. Obesity, expression of adipocytokines, and macrophage infiltration in canine mammary tumors.
Lim HY; Im KS; Kim NH; Kim HW; Shin JI; Sur JH
Vet J; 2015 Mar; 203(3):326-31. PubMed ID: 25641553
[TBL] [Abstract][Full Text] [Related]
10. Density of Gr1-positive myeloid precursor cells, p-STAT3 expression and gene expression pattern in canine mammary cancer metastasis.
Król M; Pawłowski KM; Dolka I; Musielak O; Majchrzak K; Mucha J; Motyl T
Vet Res Commun; 2011 Oct; 35(7):409-23. PubMed ID: 21713436
[TBL] [Abstract][Full Text] [Related]
11. Expression of the oncogene c-erbB-2 in canine mammary cancers and tumor-derived cell lines.
Ahern TE; Bird RC; Bird AE; Wolfe LG
Am J Vet Res; 1996 May; 57(5):693-6. PubMed ID: 8723884
[TBL] [Abstract][Full Text] [Related]
12. Plasma interleukin-1α and interleukin-8 in female dogs with non-metastatic and metastatic malignant mammary gland tumours.
Szczubiał M; Łopuszyński W; Dąbrowski R; Bochniarz M; Brodzki P
Pol J Vet Sci; 2022 Jun; 25(2):317-324. PubMed ID: 35861995
[TBL] [Abstract][Full Text] [Related]
13. Expression and significance of IL-6 and IL-8 in canine mammary gland tumors.
Ren X; Fan Y; Shi D; Liu Y
Sci Rep; 2023 Jan; 13(1):1302. PubMed ID: 36693957
[TBL] [Abstract][Full Text] [Related]
14. Intratumoral FoxP3 expression is associated with angiogenesis and prognosis in malignant canine mammary tumors.
Carvalho MI; Pires I; Prada J; Gregório H; Lobo L; Queiroga FL
Vet Immunol Immunopathol; 2016 Oct; 178():1-9. PubMed ID: 27496736
[TBL] [Abstract][Full Text] [Related]
15. Metastasis prognostic factors and cancer stem cell-related transcription factors associated with metastasis induction in canine metastatic mammary gland tumors.
Kim S; Bok E; Lee S; Lee HJ; Choe Y; Kim NH; Lee WJ; Rho GJ; Lee SL
J Vet Sci; 2021 Sep; 22(5):e62. PubMed ID: 34423600
[TBL] [Abstract][Full Text] [Related]
16. Immunosuppression in Dogs During Mammary Cancer Development.
Mucha J; Rybicka A; Dolka I; Szymańska J; Manuali E; Parzeniecka-Jaworska M; Kluciński W; Król M
Vet Pathol; 2016 Nov; 53(6):1147-1153. PubMed ID: 27106740
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of vascular endothelial growth factor and hypoxia-inducible factor 1α in canine malignant mammary tumors.
Moschetta MG; Maschio LB; Jardim-Perassi BV; Gelaleti GB; Lopes JR; Leonel C; Gonçalves Ndo N; Ferreira LC; Martins GR; Borin TF; Zuccari DA
Oncol Rep; 2015 May; 33(5):2345-53. PubMed ID: 25779537
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA expression patterns in canine mammary cancer show significant differences between metastatic and non-metastatic tumours.
Bulkowska M; Rybicka A; Senses KM; Ulewicz K; Witt K; Szymanska J; Taciak B; Klopfleisch R; Hellmén E; Dolka I; Gure AO; Mucha J; Mikow M; Gizinski S; Krol M
BMC Cancer; 2017 Nov; 17(1):728. PubMed ID: 29115935
[TBL] [Abstract][Full Text] [Related]
19. Analysis of Gene Expression Signatures in Cancer-Associated Stroma from Canine Mammary Tumours Reveals Molecular Homology to Human Breast Carcinomas.
Ettlin J; Clementi E; Amini P; Malbon A; Markkanen E
Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28531107
[TBL] [Abstract][Full Text] [Related]
20. Hormone Receptor Expression Analyses in Neoplastic and Non-Neoplastic Canine Mammary Tissue by a Bead Based Multiplex Branched DNA Assay: A Gene Expression Study in Fresh Frozen and Formalin-Fixed, Paraffin-Embedded Samples.
Mohr A; Lüder Ripoli F; Hammer SC; Willenbrock S; Hewicker-Trautwein M; Kiełbowicz Z; Murua Escobar H; Nolte I
PLoS One; 2016; 11(9):e0163311. PubMed ID: 27649560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]